Search

Your search keyword '"Quek, Jingxuan"' showing total 32 results
Start Over Author "Quek, Jingxuan"
32 results on '"Quek, Jingxuan"'

1. 400 QUALITY ASSESSMENT OF LIVER VISUALISATION THROUGH IMAGING FOR DETECTION AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA: SYSTEMATIC REVIEW AND META-ANALYSIS

Author

Quek, Jingxuan, Xiao, Jieling, Fu, Clarissa E, Tan, Darren J, Chan, Kai En, Lim, Wen Hui, Ng, Cheng Han, Syn, Nicholas L, Teng, Margaret LP, Muthiah, Mark, Loomba, Rohit, and Huang, Daniel

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Good Health and Well Being, Neurosciences, Paediatrics and Reproductive Medicine, Gastroenterology & Hepatology, Clinical sciences, Nutrition and dietetics
Published
2023

2. Placebo Adverse Events in Non-alcoholic Steatohepatitis Clinical Trials: A Pooled Analysis of 2,944 Participants

Author

Tay, Phoebe Wen Lin, Ng, Cheng Han, Lin, Snow Yunni, Chin, Yip Han, Xiao, Jieling, Lim, Wen Hui, Lim, Sze Yinn, Fu, Clarissa Elysia, Chan, Kai En, Quek, Jingxuan, Tan, Darren Jun Hao, Chew, Nicholas, Syn, Nicholas, Keitoku, Taisei, Tamaki, Nobuharu, Siddiqui, Mohammad Shadab, Noureddin, Mazen, Muthiah, Mark, Huang, Daniel Q, and Loomba, Rohit

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Hepatitis, Clinical Research, Digestive Diseases, Clinical Trials and Supportive Activities, Liver Disease, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Humans, Non-alcoholic Fatty Liver Disease, Bile Acids and Salts, Randomized Controlled Trials as Topic, Gastroenterology & Hepatology, Clinical sciences
Abstract

IntroductionIn the absence of an effective treatment for non-alcoholic steatohepatitis (NASH), a randomized, placebo-controlled trial (RCT) remains the current gold standard study design in NASH. As NASH is a largely asymptomatic disease, the side effects of potential therapies require careful evaluation, therefore a pooled rate of the adverse events (AEs) in placebo-treated patients serves as a useful comparator for safety. Therefore, we performed a systematic review and meta-analysis to estimate the rate of AEs among participants in the placebo arm of NASH RCTs.MethodsMedline, Embase and Cochrane Central Register of Controlled Trials were searched to include clinical trials in phase 2-4 NASH RCTs with placebo treatment arms. A pooled proportions of AEs were analyzed using a generalized linear mixed model with Clopper-Pearson intervals.ResultsA total of 41 RCTs (2,944 participants on placebo) were included in this meta-analysis. A total of 68% (confidence interval [CI] 55%-77%) of participants on placebo experienced an AE, 7.8% (5.7%-10%) experienced serious AEs and 3.1% (CI: 1.9%-5.1%) experienced AEs leading to discontinuation. A significantly higher proportion of participants experienced serious AEs in phase 3 studies compared to in phase 2 studies ( P < 0.01) and in pharmaceutical funded studies as compared to studies which were federal-funded studies ( P < 0.01). An analysis of clinical trials evaluating bile acid modulating agents determined that 10% (CI: 5.5%-18%) of participants receiving placebo developed pruritus.DiscussionThe present study summarizes the AEs with NASH placebo. Among participants in the placebo arm in NASH, two-third experienced an AE, and nearly 10% experienced a serious AE.

Published
2023

3. Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis

Author

Tan, Darren Jun Hao, Ng, Cheng Han, Lin, Snow Yunni, Pan, Xin Hui, Tay, Phoebe, Lim, Wen Hui, Teng, Margaret, Syn, Nicholas, Lim, Grace, Yong, Jie Ning, Quek, Jingxuan, Xiao, Jieling, Dan, Yock Young, Siddiqui, Mohammad Shadab, Sanyal, Arun J, Muthiah, Mark D, Loomba, Rohit, and Huang, Daniel Q

Subjects
Chronic Liver Disease and Cirrhosis, Rare Diseases, Liver Disease, Digestive Diseases, Liver Cancer, Hepatitis, Cancer, Good Health and Well Being, Carcinoma, Hepatocellular, Child, Cross-Sectional Studies, Humans, Liver Cirrhosis, Liver Neoplasms, Non-alcoholic Fatty Liver Disease, Oncology and Carcinogenesis, Oncology & Carcinogenesis
Abstract

BackgroundThe clinical presentation and outcomes of non-alcoholic fatty liver disease (NAFLD)-related hepatocellular carcinoma are unclear when compared with hepatocellular carcinoma due to other causes. We aimed to establish the prevalence, clinical features, surveillance rates, treatment allocation, and outcomes of NAFLD-related hepatocellular carcinoma.MethodsIn this systematic review and meta-analysis, we searched MEDLINE and Embase from inception until Jan 17, 2022, for articles in English that compared clinical features, and outcomes of NAFLD-related hepatocellular carcinoma versus hepatocellular carcinoma due to other causes. We included cross-sectional and longitudinal observational studies and excluded paediatric studies. Study-level data were extracted from the published reports. The primary outcomes were (1) the proportion of hepatocellular carcinoma secondary to NAFLD, (2) comparison of patient and tumour characteristics of NAFLD-related hepatocellular carcinoma versus other causes, and (3) comparison of surveillance, treatment allocation, and overall and disease-free survival outcomes of NAFLD-related versus non-NAFLD-related hepatocellular carcinoma. We analysed proportional data using a generalised linear mixed model. Pairwise meta-analysis was done to obtain odds ratio (OR) or mean difference, comparing NAFLD-related with non-NAFLD-related hepatocellular carcinoma. We evaluated survival outcomes using pooled analysis of hazard ratios.FindingsOf 3631 records identified, 61 studies (done between January, 1980, and May, 2021; 94 636 patients) met inclusion criteria. Overall, the proportion of hepatocellular carcinoma cases secondary to NAFLD was 15·1% (95% CI 11·9-18·9). Patients with NAFLD-related hepatocellular carcinoma were older (p75%), and all articles had low-to-moderate risk of bias.InterpretationNAFLD-related hepatocellular carcinoma is associated with a higher proportion of patients without cirrhosis and lower surveillance rates than hepatocellular carcinoma due to other causes. Surveillance strategies should be developed for patients with NAFLD without cirrhosis who are at high risk of developing hepatocellular carcinoma.FundingNone.

Published
2022

4. The Spectrum and Impact of Metabolic Dysfunction in MAFLD: A Longitudinal Cohort Analysis of 32,683 Overweight and Obese Individuals

Author

Chan, Kai En, Ng, Cheng Han, Fu, Clarissa Elysia, Quek, Jingxuan, Kong, Gwyneth, Goh, Yi Jie, Zeng, Rebecca Wenling, Tseng, Michael, Aggarwal, Manik, Nah, Benjamin, Chee, Douglas, Wong, Zhen Yu, Zhang, Sitong, Wang, Jiong-Wei, Chew, Nicholas W.S., Dan, Yock Young, Siddiqui, Mohammad Shadab, Noureddin, Mazen, Sanyal, Arun J., and Muthiah, Mark

Published
2023
Full Text
View/download PDF

5. Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysis

Author

Tang, Ansel, Ng, Cheng Han, Phang, Poh Hui, Chan, Kai En, Chin, Yip Han, Fu, Clarissa Elysia, Zeng, Rebecca Wenling, Xiao, Jieling, Tan, Darren Jun Hao, Quek, Jingxuan, Lim, Wen Hui, Mak, Lung Yi, Wang, Jiong-wei, Chew, Nicholas W.S., Syn, Nicholas, Huang, Daniel Q., Siddiqui, Mohammad Shadab, Sanyal, Arun, Muthiah, Mark, and Noureddin, Mazen

Published
2023
Full Text
View/download PDF

6. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis

Author

Quek, Jingxuan, Chan, Kai En, Wong, Zhen Yu, Tan, Caitlyn, Tan, Bryan, Lim, Wen Hui, Tan, Darren Jun Hao, Tang, Ansel Shao Pin, Tay, Phoebe, Xiao, Jieling, Yong, Jie Ning, Zeng, Rebecca Wenling, Chew, Nicholas W S, Nah, Benjamin, Kulkarni, Anand, Siddiqui, Mohammad Shadab, Dan, Yock Young, Wong, Vincent Wai-Sun, Sanyal, Arun J, Noureddin, Mazen, Muthiah, Mark, and Ng, Cheng Han

Published
2023
Full Text
View/download PDF

8. Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis

Author

En Li Cho, Elina, primary, Ang, Chong Zhe, additional, Quek, Jingxuan, additional, Fu, Clarissa Elysia, additional, Lim, Lincoln Kai En, additional, Heng, Zane En Qi, additional, Tan, Darren Jun Hao, additional, Lim, Wen Hui, additional, Yong, Jie Ning, additional, Zeng, Rebecca, additional, Chee, Douglas, additional, Nah, Benjamin, additional, Lesmana, Cosmas Rinaldi Adithya, additional, Bwa, Aung Hlaing, additional, Win, Khin Maung, additional, Faulkner, Claire, additional, Aboona, Majd B, additional, Lim, Mei Chin, additional, Syn, Nicholas, additional, Kulkarni, Anand V., additional, Suzuki, Hiroyuki, additional, Takahashi, Hirokazu, additional, Tamaki, Nobuharu, additional, Wijarnpreecha, Karn, additional, Huang, Daniel Q., additional, Muthiah, Mark, additional, Ng, Cheng Han, additional, and Loomba, Rohit, additional

Published
2023
Full Text
View/download PDF

9. The global burden of metabolic disease: Data from 2000 to 2019

Author

Chew, Nicholas W.S., primary, Ng, Cheng Han, additional, Tan, Darren Jun Hao, additional, Kong, Gwyneth, additional, Lin, Chaoxing, additional, Chin, Yip Han, additional, Lim, Wen Hui, additional, Huang, Daniel Q., additional, Quek, Jingxuan, additional, Fu, Clarissa Elysia, additional, Xiao, Jieling, additional, Syn, Nicholas, additional, Foo, Roger, additional, Khoo, Chin Meng, additional, Wang, Jiong-Wei, additional, Dimitriadis, Georgios K., additional, Young, Dan Yock, additional, Siddiqui, Mohammad Shadab, additional, Lam, Carolyn S.P., additional, Wang, Yibin, additional, Figtree, Gemma A., additional, Chan, Mark Y., additional, Cummings, David E., additional, Noureddin, Mazen, additional, Wong, Vincent Wai-Sun, additional, Ma, Ronald Ching Wan, additional, Mantzoros, Christos S., additional, Sanyal, Arun, additional, and Muthiah, Mark Dhinesh, additional

Published
2023
Full Text
View/download PDF

10. Quality Assessment of Ultrasound and Magnetic Resonance Imaging for Hepatocellular Carcinoma Surveillance: A Systematic Review and Meta-Analysis.

Author

Quek, Jingxuan, Tan, Darren Jun Hao, Chan, Kai En, Lim, Wen Hui, Ng, Cheng Han, Ren, Yi Ping, Koh, Teng Kiat, Teh, Readon, Xiao, Jieling, Fu, Clarissa, Syn, Nicholas, Teng, Margaret, Muthiah, Mark, Fowler, Kathryn J., Sirlin, Claude B., Loomba, Rohit, and Huang, Daniel Q.

Subjects
FATTY liver, MAGNETIC resonance imaging, HEPATOCELLULAR carcinoma, NON-alcoholic fatty liver disease, ULTRASONIC imaging
Abstract

Introduction: To achieve early detection and curative treatment options, surveillance imaging for hepatocellular carcinoma (HCC) must remain of quality and without substantial limitations in liver visualization. However, the prevalence of limited liver visualization during HCC surveillance imaging has not been systematically assessed. Utilizing a systematic review and meta-analytic approach, we aimed to determine the prevalence of limited liver visualization during HCC surveillance imaging. Methods: MEDLINE and Embase electronic databases were searched to identify published data on liver visualization limitations of HCC surveillance imaging. An analysis of proportions was pooled using a generalized linear mixed model with Clopper-Pearson intervals. Risk factors were analysed using a generalized mixed model with a logit link and inverse variance weightage. Results: Of 683 records, 10 studies (7,131 patients) met inclusion criteria. Seven studies provided data on liver visualization limitations on ultrasound (US) surveillance exams: prevalence of limited liver visualization was 48.9% (95% CI: 23.5–74.9%) in the overall analysis and 59.2% (95% CI: 24.2–86.9%) in a sensitivity analysis for cirrhotic patients. Meta-regression determined that non-alcoholic fatty liver disease was associated with limited liver visualization on US. Four studies provided data for liver visualization limitations in abbreviated magnetic resonance imaging (aMRI), with inadequate visualization ranging from 5.8% to 19.0%. One study provided data for complete MRI and none for computed tomography. Conclusion: A substantial proportion of US exams performed for HCC surveillance provide limited liver visualization, especially in cirrhosis, which may hinder detection of small observations. Alternative surveillance strategies including aMRI may be appropriate for patients with limited US visualization. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

11. Placebo Adverse Events in Non-alcoholic Steatohepatitis Clinical Trials: A Pooled Analysis of 2,944 Participants

Author

Tay, Phoebe Wen Lin, primary, Ng, Cheng Han, additional, Lin, Snow Yunni, additional, Chin, Yip Han, additional, Xiao, Jieling, additional, Lim, Wen Hui, additional, Lim, Sze Yinn, additional, Fu, Clarissa Elysia, additional, Chan, Kai En, additional, Quek, Jingxuan, additional, Tan, Darren Jun Hao, additional, Chew, Nicholas, additional, Syn, Nicholas, additional, Keitoku, Taisei, additional, Tamaki, Nobuharu, additional, Siddiqui, Mohammad Shadab, additional, Noureddin, Mazen, additional, Muthiah, Mark, additional, Huang, Daniel Q., additional, and Loomba, Rohit, additional

Published
2022
Full Text
View/download PDF

12. Depression in non-alcoholic fatty liver disease is associated with an increased risk of complications and mortality

Author

Ng, Cheng Han, primary, Xiao, Jieling, additional, Chew, Nicholas W. S., additional, Chin, Yip Han, additional, Chan, Kai En, additional, Quek, Jingxuan, additional, Lim, Wen Hui, additional, Tan, Darren Jun Hao, additional, Loke, Ryan Wai Keong, additional, Tan, Caitlyn, additional, Tang, Ansel Shao Pin, additional, Goh, Xin Lei, additional, Nah, Benjamin, additional, Syn, Nicholas, additional, Young, Dan Yock, additional, Tamaki, Nobuharu, additional, Huang, Daniel Q., additional, Siddiqui, Mohammad Shadab, additional, Noureddin, Mazen, additional, Sanyal, Arun, additional, and Muthiah, Mark, additional

Published
2022
Full Text
View/download PDF

13. The Spectrum and Impact of Metabolic Dysfunction in MAFLD: A Longitudinal Cohort Analysis of 32,683 Overweight and Obese Individuals

Author

Chan, Kai En, primary, Ng, Cheng Han, additional, Fu, Clarissa Elysia, additional, Quek, Jingxuan, additional, Kong, Gwyneth, additional, Goh, Yi Jie, additional, Zeng, Rebecca Wenling, additional, Tseng, Michael, additional, Aggarwal, Manik, additional, Nah, Benjamin, additional, Chee, Douglas, additional, Wong, Zhen Yu, additional, Zhang, Sitong, additional, Wang, Jiong-Wei, additional, Chew, Nicholas W.S., additional, Dan, Yock Young, additional, Siddiqui, Mohammad Shadab, additional, Noureddin, Mazen, additional, Sanyal, Arun J., additional, and Muthiah, Mark, additional

Published
2022
Full Text
View/download PDF

14. Global prevalence of depression and anxiety in patients with hepatocellular carcinoma: Systematic review and meta-analysis

Author

Tan, Darren Jun Hao, primary, Quek, Sabrina Xin Zi, additional, Yong, Jie Ning, additional, Suresh, Adithya, additional, Koh, Kaiser Xuan Ming, additional, Lim, Wen Hui, additional, Quek, Jingxuan, additional, Tang, Ansel, additional, Tan, Caitlyn, additional, Nah, Benjamin, additional, Tan, Eunice, additional, Keitoku, Taisei, additional, Muthiah, Mark D., additional, Syn, Nicholas, additional, Ng, Cheng Han, additional, Kim, Beom Kyung, additional, Tamaki, Nobuharu, additional, Ho, Cyrus Su Hui, additional, Loomba, Rohit, additional, and Huang, Daniel Q., additional

Published
2022
Full Text
View/download PDF

15. A poor perspective of self weight significantly increases adverse outcomes in non-alcoholic fatty liver disease (NAFLD)

Author

Fu, Clarissa Elysia, primary, Ng, Cheng Han, additional, Chew, Nicholas W. S., additional, Heng, Zane En Qi, additional, Chin, Yip Han, additional, Quek, Jingxuan, additional, Lim, Wen Hui, additional, Xiao, Jieling, additional, Chan, Kai En, additional, Tan, Darren Jun Hao, additional, Tan, Caitlyn, additional, Zhang, Sitong, additional, Koh, Teng Kiat, additional, Nah, Benjamin, additional, Dan, Yock Young, additional, Syn, Nicholas, additional, Siddiqui, Mohammad Shadab, additional, Sanyal, Arun J., additional, Noureddin, Mazen, additional, and Muthiah, Mark, additional

Published
2022
Full Text
View/download PDF

16. Statins decrease overall mortality and cancer related mortality but are underutilized in NAFLD: a longitudinal analysis of 12,538 individuals

Author

Ng, Cheng Han, primary, Teng, Margaret LP, additional, Chew, Nicholas WS, additional, Chan, Kai En, additional, Yong, Jie Ning, additional, Quek, Jingxuan, additional, Tan, Darren Jun Hao, additional, Lim, Wen Hui, additional, Lee, Gabriel Sheng Jie, additional, Wong, Jessica, additional, Kaewdech, Apichat, additional, Huang, Daniel Q, additional, Wang, Jiongwei, additional, Chan, Mark Y, additional, Noureddin, Mazen, additional, Siddiqui, Mohammad Shadab, additional, Sanyal, Arun, additional, and Muthiah, Mark, additional

Published
2022
Full Text
View/download PDF

18. Metabolic Associated Fatty Liver Disease Increases the Risk of Systemic Complications and Mortality. A Meta-Analysis and Systematic Review of 12 620 736 Individuals

Author

Quek, Jingxuan, primary, Ng, Cheng Han, additional, Tang, Ansel Shao Pin, additional, Chew, Nicholas, additional, Chan, Mark, additional, Khoo, Chin Meng, additional, Wei, Chen Poh, additional, Chin, Yip Han, additional, Tay, Phoebe, additional, Lim, Grace, additional, Tan, Darren Jun Hao, additional, Lim, Wen Hui, additional, Chan, Kai En, additional, Teng, Margaret, additional, Tan, Eunice, additional, Tamaki, Nobuharu, additional, Huang, Daniel Q., additional, Siddiqui, Mohammad Shadab, additional, Young, Dan Yock, additional, Noureddin, Mazen, additional, and Muthiah, Mark D., additional

Published
2022
Full Text
View/download PDF

19. Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals

Author

Tang, Ansel Shao Pin, primary, Chan, Kai En, additional, Quek, Jingxuan, additional, Xiao, Jieling, additional, Tay, Phoebe, additional, Teng, Margaret, additional, Lee, Keng Siang, additional, Lin, Snow Yunni, additional, Myint, May Zin, additional, Tan, Benjamin, additional, Sharma, Vijay K, additional, Tan, Darren Jun Hao, additional, Lim, Wen Hui, additional, Kaewdech, Apichat, additional, Huang, Daniel, additional, Chew, Nicholas WS, additional, Siddiqui, Mohammad Shadab, additional, Sanyal, Arun J, additional, Muthiah, Mark, additional, and Ng, Cheng Han, additional

Published
2022
Full Text
View/download PDF

20. A Class Effect Network Meta-analysis of Lipid Modulation in Non-alcoholic Steatohepatitis for Dyslipidemia

Author

Xiao, Jieling, primary, Ng, Cheng-Han, additional, Chin, Yip-Han, additional, Tan, Darren Jun Hao, additional, Lim, Wen-Hui, additional, Lim, Grace, additional, Quek, Jingxuan, additional, Tang, Ansel Shao Pin, additional, Chan, Kai-En, additional, Soong, Rou-Yi, additional, Chew, Nicholas, additional, Tay, Benjamin, additional, Huang, Daniel Q., additional, Tamaki, Nobuharu, additional, Foo, Roger, additional, Chan, Mark Y., additional, Noureddin, Mazen, additional, Siddiqui, Mohammad Shadab, additional, Sanyal, Arun J., additional, and Muthiah, Mark D., additional

Published
2022
Full Text
View/download PDF

21. Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals

Author

Chan, Kai En, primary, Koh, Tiffany Jia Ling, additional, Tang, Ansel Shao Pin, additional, Quek, Jingxuan, additional, Yong, Jie Ning, additional, Tay, Phoebe, additional, Tan, Darren Jun Hao, additional, Lim, Wen Hui, additional, Lin, Snow Yunni, additional, Huang, Daniel, additional, Chan, Mark, additional, Khoo, Chin Meng, additional, Chew, Nicholas W S, additional, Kaewdech, Apichat, additional, Chamroonkul, Naichaya, additional, Dan, Yock Young, additional, Noureddin, Mazen, additional, Muthiah, Mark, additional, Eslam, Mohammed, additional, and Ng, Cheng Han, additional

Published
2022
Full Text
View/download PDF

22. Antidiabetic Medications for Type 2 Diabetics with Nonalcoholic Fatty Liver Disease: Evidence From a Network Meta-Analysis of Randomized Controlled Trials

Author

Ng, Cheng Han, primary, Lin, Snow Yunni, additional, Chin, Yip Han, additional, Lee, Ming Hui, additional, Syn, Nicholas, additional, Goh, Xin Lei, additional, Koh, Jin Hean, additional, Quek, Jingxuan, additional, Hao Tan, Darren Jun, additional, Mok, Shao Feng, additional, Tan, Eunice, additional, Dan, Yock Young, additional, Chew, Nicholas, additional, Khoo, Chin Meng, additional, Siddiqui, Mohammad Shadab, additional, and Muthiah, Mark, additional

Published
2022
Full Text
View/download PDF

23. The growing prevalence of nonalcoholic fatty liver disease (NAFLD), determined by fatty liver index, amongst young adults in the United States. A 20-year experience

Author

Li, Wenhao, primary, Ng, Cheng Han, additional, Quek, Jingxuan, additional, Chan, Kai En, additional, Tan, Caitlyn, additional, Zeng, Rebecca Wenling, additional, Yong, Jie Ning, additional, Tay, Hannah, additional, Tan, Darren Jun Hao, additional, Lim, Wen Hui, additional, Chee, Douglas, additional, Ho, Jinyang, additional, Chew, Nicholas W.S., additional, Mak, Lung Yi, additional, Siddiqui, Mohammad Shadab, additional, Sanyal, Arun, additional, Alazawi, William, additional, Alkouri, Naim, additional, Muthiah, Mark, additional, and Noureddin, Mazen, additional

Published
2022
Full Text
View/download PDF

24. A meta‐analysis of the cumulative incidence, risk factors, and clinical outcomes associated with chronic kidney disease after liver transplantation

Author

Lim, Sze Yinn, primary, Wang, Renaeta, additional, Tan, Darren Jun Hao, additional, Ng, Cheng Han, additional, Lim, Wen Hui, additional, Quek, Jingxuan, additional, Syn, Nicholas, additional, Nah, Benjamin Kai Yi, additional, Wong, Emmett Tsz‐Yeung, additional, Huang, Daniel Q., additional, Vathsala, Anantharaman, additional, Siddiqui, Mohammad Shadab, additional, Fung, James, additional, Muthiah, Mark D., additional, and Tan, Eunice Xiang‐Xuan, additional

Published
2021
Full Text
View/download PDF

25. The Association of Plant-Based Diet With Cardiovascular Disease and Mortality: A Meta-Analysis and Systematic Review of Prospect Cohort Studies

Author

Quek, Jingxuan, primary, Lim, Grace, additional, Lim, Wen Hui, additional, Ng, Cheng Han, additional, So, Wei Zheng, additional, Toh, Jonathan, additional, Pan, Xin Hui, additional, Chin, Yip Han, additional, Muthiah, Mark D., additional, Chan, Siew Pang, additional, Foo, Roger S. Y., additional, Yip, James, additional, Neelakantan, Nithya, additional, Chong, Mary F. F., additional, Loh, Poay Huan, additional, and Chew, Nicholas W. S., additional

Published
2021
Full Text
View/download PDF

27. Endoscopic submucosal dissection versus endoscopic mucosal resection for rectal carcinoid tumor. A meta‐analysis and meta‐regression with single‐arm analysis

Author

Yong, Jie Ning, primary, Lim, Xiong Chang, additional, Nistala, Kameswara Rishi Yeshayahu, additional, Lim, Lincoln Kai En, additional, Lim, Grace En Hui, additional, Quek, Jingxuan, additional, Tham, Hui Yu, additional, Wong, Neng Wei, additional, Tan, Ker‐Kan, additional, and Chong, Choon Seng, additional

Published
2021
Full Text
View/download PDF

29. Mo1575 ETHNIC DISPARITIES IN OUTCOMES OF NON-ALCOHOLIC STEATOHEPATITIS PATIENTS AWAITING LIVER TRANSPLANTATION IN THE UNITED STATES

Author

Yong, Jie Ning, Nah, Benjamin, Koh, Jia Hong, Lim, Wen Hui, Ng, Cheng Han, Tan, Darren J., Chan, Kai En, Zeng, Rebecca Wenling, Xiao, Jieling, Fu, Clarissa E., Quek, Jingxuan, Tan, Caitlyn, Kaewdech, Apichat, Chee, Douglas, Wijarnpreecha, Karn, Tseng, Michael, Huang, Daniel, Muthiah, Mark, Nourredin, Mazen, Siddiqui, Mohammad, and Tan, Eunice X.

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results